Those of you with legal expertise, please clarify some things ... I was under the impression the courts did rule that INSM had infringed on portions of the patents but did not go so far as to rule on all issues and would have to do so at trial. Because of this situation the courts could not rule on damages or stop INSM from making and selling iPlex. True assessment???
If this is a good assessment than am I correct in anticipating there to be a long legal guantlet to run including a trial and anticipated appeals process. All the while INSM is positioning itself for other indications and other markets not impacted by the patents?
Finally, what is the potential that TRCA/DNA could get an injunction at any time during this long process that would require INSM to stop producing and selling iPlex? and is it possible the courts could impose a forced settlement in the form of damages or royalties?
News 
Market Data 
Discover 
